- Maintenance treatment in asthma/COPD:
- PO 300-400mg OD *3/7, then 400-600mg OD
- Max: 400mg/day if reduced clearance
- Adjunct treatment in acute bronchospasm:
- Loading:
- Patients not currently taking theophylline: PO 5-7mg/kg
- Aminophylline: IV 6-7mg/kg infused over 20 minutes
- Loading:
-
- Maintenance: PO 4.8-7.2mg/kg BD
- Maintenance: PO 4.8-7.2mg/kg BD
- Neonatal apnea:
- Loading: PO 4-5mg/kg
- Maintenance: PO 3-6mg/kg/day divided TDS
- Tablet:
- 250mg
- 400mg
- 600mg
None remarkable
Xanthine derivative
It relaxes smooth muscles of respiratory tract and suppresses the response of the airways to stimuli. It may increase tissue concentration of cyclic adenine monophosphate (cAMP), which induces release of epinephrine from the adrenal medulla cells
- Nausea
- Vomiting
- Headache
- Insomnia
- Diarrhea
- Irritability
- Restlessness
- Tremor
- Transient diuresis
- Hypersensitivity to class/components
- Dipyridamole
- Febuxostat
- Riociguat
- Viloxazine
Drug Status
Availability | Prescription only |
Pregnancy | Category C |
Breastfeeding | Contraindicated |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Nuelin SA | 250mg | Tablet | 56’s | iNova Pharma | Phillips Therapeutics |
Unicontin | 400mg | Tablet | 100’s | Modi Mundipharma | Europa Healthcare |
Unicontin | 600mg | Tablet | 100’s | Modi Mundipharma | Europa Healthcare |